Impact of the publication of the Finnish Meds75+ database on the use of potentially inappropriate medications in older persons.
aged
interrupted time-series analysis
potentially inappropriate medication list
registry study
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
17
05
2023
received:
09
01
2023
accepted:
17
05
2023
medline:
15
9
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
ppublish
Résumé
To evaluate the impact of the updated nationwide Meds75+ database and its linkage to the Finnish health portal on the use of potentially inappropriate medications (PIMs) among older persons. We also aimed to evaluate whether there is regional variation in trend changes of PIM use. Meds75+ was implemented at the population level in 2015, so randomization is unfeasible. We used a quasi-experimental interrupted time series analysis to evaluate the changes in levels and trends of PIM use. The data included all Finnish community-dwelling persons aged ≥75 years (N = 920 163) who had medication purchases in the Prescription Register during 2009-2020. Data were linked with the Care Registers for Health and Social Care and the cause of death register. The prevalence of PIMs decreased from 20.2% in 2009 to 11.7% in 2020. The change of level of the monthly PIM users was negative (β -0.036, 95% confidence interval [CI] -0.202 to 0.131), but not statistically significant (P = .673) after the publication of the database. We found a small decrease (β -0.018, 95% CI -0.083 to 0.047, P = .593) in the slope of PIM users, but it was not statistically significant. The regional results were similar to the main findings. Publication of the updated Meds75+ database did not decrease the level or trend of PIM users. In addition, this study did not show any significant regional variation in PIM use trends. Further research should focus on determining barriers and facilitators to the utilization of PIM criteria in clinical practice.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3046-3055Informations de copyright
© 2023 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173-184. doi:10.1016/S0140-6736(07)61091-5
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674-694. doi:10.1111/jgs.15767
O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020;13(1):15-22. doi:10.1080/17512433.2020.1697676
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31-32):543-551. doi:10.3238/arztebl.2010.0543
Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861-875. doi:10.1007/s00228-015-1860-9
Finnish Medicines Agency (Fimea). Meds75+. Updated 2022. Accessed June 21, 2022. https://www.fimea.fi/web/en/databases_and_registeries/medicines_information/database_of_medication_for_older_persons
Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950-964. doi:10.1097/MLR.0000000000000587
Heider D, Matschinger H, Meid AD, et al. The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study. PLoS ONE. 2018;31(7):e0198004. doi:10.1371/journal.pone.0198004
Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schöttker B. The Association of Potentially Inappropriate Medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies. J Am Med Dir Assoc. 2017;18(3):211-220. doi:10.1016/j.jamda.2016.11.025
Xu Z, Liang X, Zhu Y, et al. Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic review. Fam Med Community Health. 2021;9(4):e001325. doi:10.1136/fmch-2021-001325 Erratum in: Fam Med Community Health 2021 Dec;9(4): PMID: 34794961; PMCID: PMC8603289
Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415-1427. doi:10.1007/s00228-015-1954-4
Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1-862.e9. doi:10.1016/j.jamda.2016.06.011
Sotekuva.fi. Indicator 5036: Those aged 75 or over who have obtained medicines that should be avoided (reimbursable and non-reimbursable prescription medicines), % of the population of the same age. Accessed December 8, 2022. https://sotekuva.fi/en/#/chart?regionCategory=HYVINVOINTIALUE&searchTerm=5036®ions=658,880,881,886,889,897,877,887,895,894,879,885,892,893,882,884,888,890,878,883,898,891,896&freeze=false&sortByYear=false&absValue=false&munSortOrder=0&showMinAndMaxValues=false&showLowAndHighValues=false&showChartValues=true&previousView=chart&indicatorId=5036®ionId=658
Saastamoinen L, Verho J. Regional variation in potentially inappropriate medicine use in older adults.-a national register-based cross-sectional study on economic, health system-related and patient-related characteristics. Res Social Adm Pharm. 2021;17(6):1223-1227. doi:10.1016/j.sapharm.2020.08.018
Drusch S, Le Tri T, Ankri J, Zureik M, Herr M. Decreasing trends in potentially inappropriate medications in older people: a nationwide repeated cross-sectional study. BMC Geriatr. 2021;21(1):621. doi:10.1186/s12877-021-02568-1
Selke Krulichová I, Selke GW, Thürmann PA. Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany. Eur J Clin Pharmacol. 2021;77(10):1553-1561. doi:10.1007/s00228-021-03148-3
Rigobon AV, Kalia S, Nichols J, et al. Impact of the diabetes Canada guideline dissemination strategy on the prescription of vascular protective medications: a retrospective cohort study, 2010-2015. Diabetes Care. 2019;42(1):148-156. doi:10.2337/dc18-0935
Greiver M, Kalia S, Moineddin R, Chen S, Duchen R, Rigobon A. Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study. BMC Health Serv Res. 2020;20(1):370. doi:10.1186/s12913-020-05232-3
Jang S, Jeong S, Kang E, Jang S. Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: an interrupted time series with segmented regression analysis. Pharmacoepidemiol Drug Saf. 2021;30(1):17-27. doi:10.1002/pds.5140
Rantsi M, Hyttinen V, Jyrkkä J, Vartiainen AK, Kankaanpää E. Process evaluation of implementation strategies to reduce potentially inappropriate medication prescribing in older population: a scoping review. Res Social Adm Pharm. 2022;18(3):2367-2391. doi:10.1016/j.sapharm.2021.04.012
World Health Organization. Anatomical therapeutic chemical (ATC) classification. Updated 2022. Accessed June 9, 2022. https://www.who.int/tools/atc-ddd-toolkit/atc-classification
Finnish Statistics on Medicines 2020. Finnish Medicines Agency Fimea and Social Insurance Institution. Helsinki 2021. ISSN 2490-0109. Accessed November 3, 2022. https://www.julkari.fi/bitstream/handle/10024/143552/Finnish_statistics_on_medicines_2020.pdf?sequence=1&isAllowed=y
Social Insurance Institution (SII) of Finland. Reimbursements for medicine expenses. Updated 2022. Accessed June 9, 2022. https://www.kela.fi/web/en/medicine-expenses
Rikala M, Hartikainen S, Saastamoinen LK, Korhonen MJ. Measuring psychotropic drug exposures in register-based studies-validity of a dosage assumption of one unit per day in older Finns. Int J Methods Psychiatr Res. 2013;22(2):155-165. doi:10.1002/mpr.1384
Hategeka C, Ruton H, Karamouzian M, Lynd LD, Law MR. Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review. BMJ Glob Health. 2020;5(10):e003567. doi:10.1136/bmjgh-2020-003567
Schaffer AL, Dobbins TA, Pearson SA. Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions. BMC Med Res Methodol. 2021;21(1):58. doi:10.1186/s12874-021-01235-8
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348-355. doi:10.1093/ije/dyw098 Erratum in: Int J Epidemiol. 2020 Aug 1;49(4):1414
Hyndman RJ, Athanasopoulos G. Forecasting: principles and practice. 3rd ed. OTexts; 2021. Accessed June 28, 2022. OTexts.com/fpp3
The Association of Finnish Pharmacies 2022. Annual review of the Association of Finnish Pharmacies 2017. Accessed November 3, 2022. https://www.apteekkariliitto.fi/media/3-apteekkariliitto.fi/englanti/annual-reviews/annual_report_2017.pdf
Dalton K, O'Brien G, O'Mahony D, Byrne S. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis. Age Ageing. 2018;47(5):670-678. doi:10.1093/ageing/afy086
Vanderman AJ, Moss JM, Bryan WE 3rd, Sloane R, Jackson GL, Hastings SN. Evaluating the impact of medication safety alerts on prescribing of potentially inappropriate medications for older veterans in an ambulatory care setting. J Pharm Pract. 2017;30(1):82-88. doi:10.1177/0897190015621803 Epub 2016 Jul 9
Smith DH, Perrin N, Feldstein A, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med. 2006;166(10):1098-1104. doi:10.1001/archinte.166.10.1098
Hyttinen V, Jyrkkä J, Saastamoinen LK, Vartiainen AK, Valtonen H. The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study. Eur J Health Econ. 2019;20(2):233-243. doi:10.1007/s10198-018-0992-0 Epub 2018 Jul 5
Pharma Industry Finland. Reimbursability of medicines. Accessed November 24, 2022. https://www.pif.fi/medicines/reimbursability-of-medicines.html
Tanskanen A, Taipale H, Koponen M, et al. From prescription drug purchases to drug use periods-a second generation method (PRE2DUP). BMC Med Inform Decis Mak. 2015;15:21. doi:10.1186/s12911-015-0140-z
Paulamäki J, Jyrkkä J, Hyttinen V, Jämsen E. Prevalence of potentially inappropriate medication use in older population: comparison of the Finnish Meds75+ database with eight published criteria. BMC Geriatr. 2023;23(1):139. doi:10.1186/s12877-022-03706-z
Langford AV, Chen TF, Roberts C, Schneider CR. Measuring the impact of system level strategies on psychotropic medicine use in aged care facilities: a scoping review. Res Social Adm Pharm. 2020;16(6):746-759. doi:10.1016/j.sapharm.2019.08.035 Epub 2019 Aug 20
Mielikäinen L, Kuronen R. Sosiaalihuollon laitos- ja asumispalvelut 2021. Sosiaalihuollon ympärivuorokautisissa laitos- ja asumispalveluissa vuoden aikana yli 100 000 asiakasta. Tilastoraportti 26/2022. Available online (only in Finnish): Accessed November 4, 2022. https://urn.fi/URN:NBN:fi-fe2022061546605